Company page
Vaxcell-bio Therapeutics
Vaxcell-bio Therapeutics is a public company listed under the ticker 323990 on the Korean market. The company has a market capitalization of approximately 90.9 million USD. Vaxcell-bio focuses on developing innovative therapeutic solutions in the biotechnology sector.
- Ticker
- 323990
- Market cap
- $90.9M
- Sector
- Health Technology
- Industry
- Biotechnology